EPROTEIN DISCOVERY
"EPROTEIN DISCOVERY" is a trademark owned by Nuclera Ltd, filed at the WIPO on July 25, 2023. It is registered and covers classes 1, 5, 9 and 10.
- Status
- Registered
- Filed
- July 25, 2023
- Registered
- Not yet
- Expires
- July 25, 2033
- Application no.
- Not recorded
- Registration no.
- 1757107
- Office
- WIPO
- World Intellectual Property Organization
- Mark type
- Trademark
- 4 classes
Who owns EPROTEIN DISCOVERY
The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.
Owner
Nuclera Ltd
United Kingdom
Representative
Rebecca Liebowitz
Venable LLP
What the mark covers
The products and services EPROTEIN DISCOVERY is filed for, grouped by Nice class.
Chemicals for scientific purposes; chemical preparations, enzymes, gene editing enzymes, DNA, RNA, oligonucleotides, genes and proteins for scientific and industrial purposes; nucleic acids comprising natural and synthetic nucleotides and oligonucleotides for scientific and industrial purposes; synthetic DNA, synthetic RNA, synthetic genes, synthetic oligonucleotides and synthetic proteins for scientific and industrial use; chemicals, reagents and enzymes for use in the preparation and creation of DNA, RNA, genes and proteins; molecular biology research tools in the nature of biological and biochemical reagents; molecular biology research tools in the nature of chemical, biological and biochemical reagents used for the synthesis of DNA, RNA, oligonucleotides, genes and proteins for scientific and industrial purposes.
Pharmaceutical and veterinary preparations, including nucleic acids comprising natural and synthetic nucleotides and oligonucleotides for medical and veterinary purposes; biological, chemical and biochemical reagents, including DNA and RNA products, proteins, gene editing enzymes for clinical or medical use; synthetic DNA, synthetic RNA, synthetic genes, synthetic oligonucleotides, synthetic proteins for clinical or medical use; DNA and RNA products for medical use; therapeutic DNA and RNA products; vaccines.
Scientific laboratory apparatus and instruments; scientific desktop instruments for DNA, RNA, gene and protein synthesis; cartridges for use in scientific apparatus in connection with DNA, RNA, gene, cell, and protein synthesis and characterization instruments; semiconductors; semiconductor chips; microchips; biosensors; biochips; apparatus and instruments for amplifying DNA and RNA; apparatus and instruments for synthesising DNA and RNA; apparatus and instruments for processing DNA and RNA; computer hardware, computer software, downloadable computer software, bioinformatics software; parts and fittings for all the aforesaid goods; all for use in DNA, RNA, gene and protein synthesis in the fields of biotechnology and medical science.
Medical apparatus and instruments; apparatus and instruments for DNA and RNA analysis, sequencing and synthesis for medical and veterinary purposes; apparatus for DNA, RNA, gene and protein synthesis for medical and veterinary purposes.
About EPROTEIN DISCOVERY
Who owns the trademark "EPROTEIN DISCOVERY"?
The WIPO trademark "EPROTEIN DISCOVERY" is owned by Nuclera Ltd.
What is the status of "EPROTEIN DISCOVERY"?
Its status at the WIPO is: registered.
Get this data via the API
Everything on this page comes from the Signa API. Pull EPROTEIN DISCOVERY and marks like it into your own product with one request.
GET/v1/trademarks/{id}The full record: owners, classes, dates and images
GET/v1/trademarks/{id}/eventsEvery step in the office history
GET/v1/proceedings?trademark_id={id}Oppositions and cancellations against the mark
ID=tm_d2895b31-f314-4096-ad12-041768f257d0
curl https://api.signa.so/v1/trademarks/$ID \
-H "Authorization: Bearer $SIGNA_API_KEY"{
"id": "tm_d2895b31-f314-4096-ad12-041768f257d0",
"object": "trademark",
"mark_text": "EPROTEIN DISCOVERY",
"status": {
"primary": "active",
"stage": "registered"
},
"office_code": "WO",
"application_number": null,
"filing_date": "2023-07-25",
"nice_classes": [
1,
5,
9,
10
],
"owners": [
{
"name": "Nuclera Ltd",
"entity_id": "ent_019eb70d-6467-76f6-9268-4797c26057c0"
}
]
}